Prospective Study of Hemoglobin A1c and Incident Carotid Artery Plaque in Chinese Adults Without Diabetes
Overview
Endocrinology
Affiliations
Background: Diabetes has been reported to be associated with carotid artery plaque (CAP). However, it remains unclear whether hemoglobin A1c (HbA1c) level, a marker for long-term glycemic status, is associated with altered CAP risk in individuals with fasting blood glucose (FBG) concentrations below the current cutoff for diabetes.
Methods: Included were 16,863 Chinese adults (aged 18 years or more; 9855 men and 7008 women) with fasting blood glucose < 7.0 mmol/L at baseline (2013). Both HbA1c level and CAP (assessed via ultrasound B-mode imaging) were annually assessed during 2014-2018. All the participants were further classified into three groups based on baseline HbA1c level: ≤ 5.6%, 5.7-6.4%, and ≥ 6.5%. We used Cox proportional-hazards model to evaluate the association between HbA1c level and incident CAP, adjusting for a series of potential confounders.
Results: During 5 years of follow up, 3942 incident CAP cases were identified. Individuals with higher baseline HbA1c had higher future risk of CAP (p-trend < 0.001). In the full-adjusted model, each percent increase of HbA1c was associated with a 56% (HR = 1.56, 95% CI 1.37, 1.78) higher risk of CAP. Excluding participants with chronic inflammation, as assessed by high-sensitivity C-reactive protein and white blood cell, and those with FBG ≥ 5.6 mmol/L at baseline generated similar results.
Conclusions: Elevated HbA1c level was associated with high risk of developing CAP in Chinese adults without FBG defined diabetes.
Cao L, Yu P, Zhang L, Yao Q, Zhou F, Li X Nutr J. 2025; 24(1):1.
PMID: 39754172 PMC: 11697753. DOI: 10.1186/s12937-024-01070-9.
Yang T, Zheng H, Pan G, Guo R, Liu F, Liu S Cardiovasc Diabetol. 2023; 22(1):299.
PMID: 37919791 PMC: 10623780. DOI: 10.1186/s12933-023-02015-y.
Cheng Q, Zhou D, Wang J, Nie Z, Feng X, Huang Y Clin Cardiol. 2022; 46(1):22-31.
PMID: 36229937 PMC: 9849433. DOI: 10.1002/clc.23931.
Taya N, Katakami N, Mita T, Okada Y, Wakasugi S, Yoshii H Cardiovasc Diabetol. 2021; 20(1):95.
PMID: 33947398 PMC: 8097791. DOI: 10.1186/s12933-021-01288-5.